These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22217246)

  • 1. Drugs in preclinical and early-stage clinical development for pancreatic cancer.
    Asuthkar S; Rao JS; Gondi CS
    Expert Opin Investig Drugs; 2012 Feb; 21(2):143-52. PubMed ID: 22217246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cetuximab: still an option in the treatment of pancreatic cancer?
    Faloppi L; Andrikou K; Cascinu S
    Expert Opin Biol Ther; 2013 May; 13(5):791-801. PubMed ID: 23560505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current aspects of chemotherapy of metastatic pancreatic and biliary tract carcinomas].
    Bokemeyer C; Kollmannsberger C; Oettle H; Kanz L
    Praxis (Bern 1994); 2000 Sep; 89(39):1545-52. PubMed ID: 11068508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of advanced pancreatic cancer.
    Li J; Podoltsev N; Saif MW
    Expert Rev Clin Pharmacol; 2009 Sep; 2(5):527-41. PubMed ID: 22112226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging cell-cycle inhibitors for pancreatic cancer therapy.
    Bayraktar S; Rocha Lima CM
    Expert Opin Emerg Drugs; 2012 Dec; 17(4):571-82. PubMed ID: 23126234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic cancer: updates on translational research and future applications.
    Sarris EG; Syrigos KN; Saif MW
    JOP; 2013 Mar; 14(2):145-8. PubMed ID: 23474558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment options for advanced pancreatic cancer: a review.
    Warsame R; Grothey A
    Expert Rev Anticancer Ther; 2012 Oct; 12(10):1327-36. PubMed ID: 23176620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-gene signaling pathways in pancreatic cancer.
    Drakaki A; Iliopoulos D
    Biomed J; 2013; 36(5):200-8. PubMed ID: 24225187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of systemic therapy in advanced pancreatic carcinoma.
    Lideståhl A; Permert J; Linder S; Bylund H; Edsborg N; Lind P
    Acta Oncol; 2006; 45(2):136-43. PubMed ID: 16546858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer: medical management (novel chemotherapeutics).
    Páez D; Labonte MJ; Lenz HJ
    Gastroenterol Clin North Am; 2012 Mar; 41(1):189-209. PubMed ID: 22341258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging pathways and future targets for the molecular therapy of pancreatic cancer.
    Vaccaro V; Melisi D; Bria E; Cuppone F; Ciuffreda L; Pino MS; Gelibter A; Tortora G; Cognetti F; Milella M
    Expert Opin Ther Targets; 2011 Oct; 15(10):1183-96. PubMed ID: 21819318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locally advanced pancreatic cancer: current therapeutic approach.
    Cardenes HR; Chiorean EG; Dewitt J; Schmidt M; Loehrer P
    Oncologist; 2006 Jun; 11(6):612-23. PubMed ID: 16794240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic cancer: progress in cancer therapy.
    Pierantoni C; Pagliacci A; Scartozzi M; Berardi R; Bianconi M; Cascinu S
    Crit Rev Oncol Hematol; 2008 Jul; 67(1):27-38. PubMed ID: 18356073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging drugs in the treatment of pancreatic cancer.
    Mahalingam D; Kelly KR; Swords RT; Carew J; Nawrocki ST; Giles FJ
    Expert Opin Emerg Drugs; 2009 Jun; 14(2):311-28. PubMed ID: 19466902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of systemic therapy for advanced pancreatic cancer.
    El-Rayes BF; Philip PA
    Clin Adv Hematol Oncol; 2003 Jul; 1(7):430-4. PubMed ID: 16258429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancements in the management of pancreatic cancer: 2013.
    Saif MW
    JOP; 2013 Mar; 14(2):112-8. PubMed ID: 23474549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyurea and trimidox enhance the radiation effect in human pancreatic adenocarcinoma cells.
    Leyden D; Ahmed N; Hassan HT
    Anticancer Res; 2000; 20(1A):133-8. PubMed ID: 10769645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-angiogenesis therapy in pancreatic carcinoma.
    Saif MW
    JOP; 2006 Mar; 7(2):163-73. PubMed ID: 16525200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.